Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Enanta Pharmaceuticals Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +2 vs. Q4 2023
- Shares held
- 22.4M
- +2.38M (+11.9%) vs. Q4 2023
- Total value
- $391.4M
- +$203.0M (+107.7%) vs. Q4 2023
- New holders
- 16
- 26 more added
- Sold out
- 14
- 51 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $397.2M |
| Q1 2026 | 133 | $338.1M |
| Q4 2025 | 132 | $416.1M |
| Q3 2025 | 122 | $227.1M |
| Q2 2025 | 108 | $139.4M |
| Q1 2025 | 110 | $102.8M |
| Q4 2024 | 108 | $114.5M |
| Q3 2024 | 112 | $220.0M |
| Q2 2024 | 101 | $287.0M |
| Q1 2024 | 108 | $391.4M |
| Q4 2023 | 106 | $188.4M |
| Q3 2023 | 132 | $225.0M |
| Q2 2023 | 134 | $438.4M |
| Q1 2023 | 145 | $805.3M |
| Q4 2022 | 147 | $894.5M |
| Q3 2022 | 160 | $1.02B |
| Q2 2022 | 155 | $956.3M |
| Q1 2022 | 170 | $1.40B |
| Q4 2021 | 181 | $1.40B |
| Q3 2021 | 149 | $1.10B |
| Q2 2021 | 152 | $828.7M |
| Q1 2021 | 150 | $956.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Enanta Pharmaceuticals Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 933,356 | $16.3M | 0.00% | −2,137−0.2% | Reduced |
| Marshall Wace, LLP | 951,062 | $16.6M | 0.03% | +951,062 | New |
| Krensavage Asset Management, LLC | 1,124,586 | $19.6M | 8.71% | +381,762+51.4% | Added |
| Armistice Capital, LLC | 1,236,000 | $21.6M | 0.57% | −828,000−40.1% | Reduced |
| BlackRock Inc. | 1,839,055 | $32.1M | 0.00% | −95,656−4.9% | Reduced |
| Vanguard Group Inc | 1,928,078 | $33.7M | 0.00% | +134,292+7.5% | Added |
| Morgan Stanley | 2,045,145 | $35.7M | 0.00% | +872,087+74.3% | Added |
| Farallon Capital Management, L.L.C. | 2,095,000 | $36.6M | 0.22% | +70,000+3.5% | Added |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −106,403−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −46,489−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −45,900−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −42,415−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −31,868−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −29,641−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −28,770−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −27,895−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −14,028−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −13,360−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −10,460−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −504−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −67−100.0% | Sold out |